How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?

Transplant International

Volumn 25, Issue 6, 2012, Pages 671-679

  Uemura, Tadahiro ^a   Nikkel, Lucas E ^a   Hollenbeak, Christopher S ^a   Ramprasad, Varun ^a   Schaefer, Eric ^a   Kadry, Zakiyah ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

advanced aged donor; donation after cardiac death; donor risk index; United Network for Organ Sharing

Indexed keywords

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DONOR RISK INDEX; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HEART DEATH; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; LIVER; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; ORGAN PATIENT INDEX; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861186356     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01474.x     Document Type: Conference Paper

References (46)

1. United Network for Organ Sharing. Available at:, 2009.
2. Detre KM, Lombardero M, Belle S, et al. Influence of donor age on graft survival after liver transplantation-United Network for Organ Sharing Registry. Liver Transpl Surg 1995; 1: 311.
3. Hoofnagle JH, Lombardero M, Zetterman RK, et al. Donor age and outcome of liver transplantation. Hepatology 1996; 24: 89.
4. Khapra AP, Agarwal K, Fiel MI, et al. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl 2006; 12: 1496.
5. Lake JR, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Wiesner RH,. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 2005; 5: 549.
6. Mutimer DJ, Gunson B, Chen J, et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 2006; 81: 7.
7. Selzner M, Kashfi A, Selzner N, et al. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation. Liver Transpl 2009; 15: 1288.
8. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202.
9. Machicao VI, Bonatti H, Krishna M, et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004; 77: 84.
10. Rayhill SC, Wu YM, Katz DA, et al. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation 2007; 84: 331.
11. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783.
12. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM,. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419.
13. Avolio AW, Siciliano M, Barbarino R, et al. Donor risk index and organ patient index as predictors of graft survival after liver transplantation. Transplant Proc 2008; 40: 1899.
14. Uemura T, Schaefer E, Hollenbeak CS, Khan A, Kadry Z,. Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid. Transpl Int 2011; 24: 640.
15. Wali M, Harrison RF, Gow PJ, Mutimer D,. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51: 248.
16. Russo MW, Galanko JA, Zacks SL, Beavers KL, Fried MW, Shrestha R,. Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis C. Am J Transplant 2004; 4: 1133.
17. Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ,. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation 2005; 80: 145.
18. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673.
19. Gonzalez FX, Rimola A, Grande L, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994; 20: 565.
20. Rull R, Vidal O, Momblan D, et al. Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation. Liver Transpl 2003; 9: 389.
21. Gruenberger T, Steininger R, Sautner T, Mittlbock M, Muhlbacher F,. Influence of donor criteria on postoperative graft function after orthotopic liver transplantation. Transpl Int 1994; 7 (Suppl. 1): S672.
22. Howell C, Jeffers L, Hoofnagle JH,. Hepatitis C in African Americans: summary of a workshop. Gastroenterology 2000; 119: 1385.
23. Kallwitz ER, Layden-Almer J, Dhamija M, et al. Ethnicity and body mass index are associated with hepatitis C presentation and progression. Clin Gastroenterol Hepatol 2010; 8: 72.
24. Verma S, Bonacini M, Govindarajan S, Kanel G, Lindsay KL, Redeker A,. More advanced hepatic fibrosis in hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis. Am J Gastroenterol 2006; 101: 1817.
25. Lake JR,. Immunosuppression and outcomes of patients transplanted for hepatitis C. J Hepatol 2006; 44: 627.
26. Fujita S, Mizuno S, Fujikawa T, et al. Liver transplantation from donation after cardiac death: a single center experience. Transplantation 2007; 84: 46.
27. Merion RM, Pelletier SJ, Goodrich N, Englesbe MJ, Delmonico FL,. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg 2006; 244: 555.
28. Abt PL, Desai NM, Crawford MD, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004; 239: 87.
29. Pine JK, Aldouri A, Young AL, et al. Liver transplantation following donation after cardiac death: an analysis using matched pairs. Liver Transpl 2009; 15: 1072.
30. Foley DP, Fernandez LA, Leverson G, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 2005; 242: 724.
31. Grewal HP, Willingham DL, Nguyen J, et al. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl 2009; 15: 1028.
32. Manzarbeitia CY, Ortiz JA, Jeon H, et al. Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation 2004; 78: 211.
33. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA,. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307.
34. Amin MG, Wolf MP, TenBrook Jr JA, et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 2004; 10: 1468.
35. Burr AT, Shah SA,. Disparities in organ allocation and access to liver transplantation in the USA. Expert Rev Gastroenterol Hepatol 2010; 4: 133.
36. Kemmer N, Safdar K, Kaiser T, Zacharias V, Neff GW,. Impact of geographic location on access to liver transplantation among ethnic minorities. Transplantation 2008; 85: 166.
37. Roberts JP, Dykstra DM, Goodrich NP, Rush SH, Merion RM, Port FK,. Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant 2006; 6: 2470.
38. Barshes NR, Becker NS, Washburn WK, Halff GA, Aloia TA, Goss JA,. Geographic disparities in deceased donor liver transplantation within a single UNOS region. Liver Transpl 2007; 13: 747.
39. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
40. Forns X, Garcia-Retortillo M, Serrano T, et al. Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol 2003; 39: 389.
41. Everson GT, Trotter J, Forman L, et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 2005; 42: 255.
42. Nudo CG, Cortes RA, Weppler D, Schiff ER, Tzakis AG, Regev A,. Effect of pretransplant hepatitis C virus RNA status on posttransplant outcome. Transplant Proc 2008; 40: 1449.
43. Yilmaz N, Shiffman ML, Stravitz RT, et al. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Liver Transpl 2007; 13: 975.
44. Zekry A, Whiting P, Crawford DH, et al. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transpl 2003; 9: 339.
45. Feray C, Gigou M, Samuel D, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1088.
46. Vargas HE, Laskus T, Wang LF, et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998; 4: 22.